Global Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Forecast 2024-2030- Product Image

Sale

Global Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Forecast 2024-2030

Report
194 Pages
March 2024
Region: Global
360iResearch™
ID: 5639504

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Postpartum Depression Treatment Market size was estimated at USD 948.54 million in 2023, USD 1,026.86 million in 2024, and is expected to grow at a CAGR of 8.74% to reach USD 1,705.58 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Postpartum Depression Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Postpartum Depression Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Depression Treatment Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Ltd., Alvogen Group Inc, Anikem Laboratories, AstraZeneca PLC, Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck A/S, Intas Pharmaceuticals Ltd., Lupin Ltd., Mylan N.V., Novartis AG, Pfizer, Inc., Sage Therapeutics, Inc., Sebela Pharmaceuticals, Inc., Shionogi & Company, Limited, Solvay S.A., Sumika Polymer Compounds (EU) Ltd, Sun Pharmaceutical Industries Limited, and Teva Pharmaceuticals Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Postpartum Depression Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
- Antidepressant Drugs
  - Bupropion
  - Desipramine
  - Escitalopram
  - Paroxetine
  - Sertraline
  - Tranylcypromine
  - Trimipramine
- Psychotherapy
  - Cognitive Behavioral Therapy
  - Interpersonal Psychotherapy
  - Psychodynamic Psychotherapy
  - Solution-Focused Brief Psychotherapy
Distribution
- Drug Stores
- E-Commerce
- Hospital Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Postpartum Depression Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Postpartum Depression Treatment Market?
What are the technology trends and regulatory frameworks in the Postpartum Depression Treatment Market?
What is the market share of the leading vendors in the Postpartum Depression Treatment Market?
Which modes and strategic moves are suitable for entering the Postpartum Depression Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Postpartum Depression Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalences of mood disorder associated with pregnancy across the globe
5.1.1.2. Growing demand for antidepressant medication and talk therapies
5.1.1.3. Increasing approvals from regulatory bodies for PPD treatment
5.1.2. Restraints
5.1.2.1. Limited availability of medical professionals
5.1.3. Opportunities
5.1.3.1. Growing availability of telehealth and telemedicine
5.1.3.2. Rising research activities for treatment of Postpartum Depression Treatment (PPD) in emerging markets
5.1.4. Challenges
5.1.4.1. Issues related to product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Postpartum Depression Treatment Market, by Treatment Type

6.1. Introduction
6.2. Antidepressant Drugs
6.3.1. Bupropion
6.3.2. Desipramine
6.3.3. Escitalopram
6.3.4. Paroxetine
6.3.5. Sertraline
6.3.6. Tranylcypromine
6.3.7. Trimipramine
6.3. Psychotherapy
6.4.1. Cognitive Behavioral Therapy
6.4.2. Interpersonal Psychotherapy
6.4.3. Psychodynamic Psychotherapy
6.4.4. Solution-Focused Brief Psychotherapy

7. Postpartum Depression Treatment Market, by Distribution

7.1. Introduction
7.2. Drug Stores
7.3. E-Commerce
7.4. Hospital Pharmacies
7.5. Retail Pharmacies

8. Americas Postpartum Depression Treatment Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Postpartum Depression Treatment Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Postpartum Depression Treatment Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Accord Healthcare Ltd.
12.1.2. Alvogen Group Inc
12.1.3. Anikem Laboratories
12.1.4. AstraZeneca PLC
12.1.5. Bausch Health Companies Inc.
12.1.6. Cipla Limited
12.1.7. Eli Lilly and Company
12.1.8. GlaxoSmithKline PLC
12.1.9. H. Lundbeck A/S
12.1.10. Intas Pharmaceuticals Ltd.
12.1.11. Lupin Ltd.
12.1.12. Mylan N.V.
12.1.13. Novartis AG
12.1.14. Pfizer, Inc.
12.1.15. Sage Therapeutics, Inc.
12.1.16. Sebela Pharmaceuticals, Inc.
12.1.17. Shionogi & Company, Limited
12.1.18. Solvay S.A.
12.1.19. Sumika Polymer Compounds (EU) Ltd
12.1.20. Sun Pharmaceutical Industries Limited
12.1.21. Teva Pharmaceuticals Industries Ltd.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. POSTPARTUM DEPRESSION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POSTPARTUM DEPRESSION TREATMENT MARKET DYNAMICS
FIGURE 7. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 10. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. POSTPARTUM DEPRESSION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 8. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 17. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 22. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 41. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 42. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 46. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 63. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 64. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 67. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 68. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 75. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 99. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 100. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 113. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 116. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 120. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 121. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 125. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 129. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 134. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 136. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 137. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 148. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 149. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 152. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 153. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 154. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 156. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 157. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 173. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 184. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 185. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 194. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 195. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 196. POSTPARTUM DEPRESSION TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

Accord Healthcare Ltd.
Alvogen Group Inc
Anikem Laboratories
AstraZeneca PLC
Bausch Health Companies Inc.
Cipla Limited
Eli Lilly and Company
GlaxoSmithKline PLC
H. Lundbeck A/S
Intas Pharmaceuticals Ltd.
Lupin Ltd.
Mylan N.V.
Novartis AG
Pfizer, Inc.
Sage Therapeutics, Inc.
Sebela Pharmaceuticals, Inc.
Shionogi & Company, Limited
Solvay S.A.
Sumika Polymer Compounds (EU) Ltd
Sun Pharmaceutical Industries Limited
Teva Pharmaceuticals Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.02 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.7 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	21

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Postpartum Depression Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

Antidepressants Global Market Report 2024

Global Anxiety and Depression Treatment Market Report and Forecast 2023-2031

Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

About the Postpartum Depression Drug Market